Investor Presentaiton

Innovation and therapeutic focus Do + R&D investor presentation • Further raise the innovation-bar for diabetes treatment • Develop a leading portfolio of superior treatment solutions for obesity • • Strengthen and progress the Biopharm pipeline Establish presence in other serious chronic diseases focusing on CVD, NASH and CKD Martin Lange SVP Global Development CVD: Cardiovascular disease; NASH: Non-alcoholic steatohepatitis; CKD: Chronic kidney disease.

View entire presentation